Recombinant Protochlamydia amoebophila Methionyl-tRNA formyltransferase (fmt)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us for preferential development.
Synonyms
fmt; pc0404Methionyl-tRNA formyltransferase; EC 2.1.2.9
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-318
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Protochlamydia amoebophila (strain UWE25)
Target Names
fmt
Target Protein Sequence
MRNRKMKVIF FGTPLFAAQV LEFLLQNQVE VVAVISKPDR PKGRSSIPVP TPVKLIAQSY HLPLYQPEVV SSLDFAPVLK NYEADLFVVV AYGEIIKQHL LDMPKRACIN LHASLLPKYR GAAPIQRSII EGEKETGVTI MHMVKKMDAG DMIKKVSVQI TSEMTYGELE QALCQIGKHA LLEVIKQFDR GEPSRQIQDS HLATFAPKIE LEDCELDWNQ SAQHLHDLVR GVNPYPGAWC YVKVNGEQKR LKISRTRVIP YPSNCPGTIL DSSKGNLKIL TGDQALELVE VQLEGKKTMT SEQWIRGMSK NQLKFLVN
Uniprot No.

Target Background

Function
This protein adds a formyl group to the free amino group of methionyl-tRNA(fMet). The formyl group plays a dual role in initiator identification of N-formylmethionyl-tRNA by promoting recognition by IF2 and preventing misappropriation of this tRNA by the elongation apparatus.
Database Links

KEGG: pcu:pc0404

STRING: 264201.pc0404

Protein Families
Fmt family

Q&A

Basic Research Questions

  • What is the biochemical function of Protochlamydia amoebophila Methionyl-tRNA formyltransferase and how does it differ from other bacterial homologs?

Protochlamydia amoebophila Methionyl-tRNA formyltransferase (fmt) catalyzes the N-formylation of methionyl-tRNA (Met-tRNA) to produce formylmethionyl-tRNA (fMet-tRNA), which is crucial for translation initiation in bacteria, mitochondria, and chloroplasts. This enzyme belongs to the family of transferases that transfer one-carbon groups, specifically hydroxymethyl-, formyl- and related transferases .

The systematic reaction catalyzed is:
10formyltetrahydrofolate+L-methionyl-tRNAfMet+H2Otetrahydrofolate+N-formylmethionyl-tRNAfMet10-\text{formyltetrahydrofolate} + \text{L-methionyl-tRNA}^{\text{fMet}} + \text{H}_2\text{O} \rightarrow \text{tetrahydrofolate} + N\text{-formylmethionyl-tRNA}^{\text{fMet}}

Unlike fmt enzymes from non-Chlamydiales bacteria, P. amoebophila fmt appears in the core gene set (represented in all 37 Chlamydiales genomes analyzed), reflecting its essential role in this bacterial order . This evolutionary conservation suggests potential structural or functional adaptations specific to the Chlamydiales lifestyle, including its role as an endosymbiont.

  • What expression systems work best for producing recombinant P. amoebophila fmt?

For optimal expression of recombinant P. amoebophila fmt, an E. coli-based expression system has been demonstrated to be effective, similar to approaches used for human mitochondrial MTF and E. coli MTF .

Methodology:

  • Host strain: E. coli BL21(DE3) or similar strains that lack endogenous proteases

  • Vector: pET-based vectors containing T7 promoter

  • Tags: N-terminal His6-tag for purification

  • Induction: 0.5-1.0 mM IPTG at OD600 of 0.6-0.8

  • Growth temperature: 25-30°C post-induction (to enhance solubility)

  • Duration: 16-18 hours for expression

Expression yield can be optimized by adjusting the codon usage of the P. amoebophila fmt gene to match E. coli codon bias, as Chlamydiales often have different GC content and codon preferences compared to E. coli .

  • How should enzymatic activity of recombinant P. amoebophila fmt be measured and validated?

The activity of recombinant P. amoebophila fmt can be measured through several complementary approaches:

In vitro formylation assay:

  • Prepare Met-tRNA by aminoacylation reaction using methionyl-tRNA synthetase (MetRS)

  • Incubate Met-tRNA with recombinant fmt and 10-formyltetrahydrofolate (10-CHO-THF)

  • Separate and quantify the formylated and non-formylated tRNA species using acid urea PAGE followed by Northern blotting with probes specific to tRNA^fMet

Detection of formylation by LC-MS/MS:
Monitor the formation of DHF as a by-product of the formylation reaction when using 10-CHO-DHF as substrate

Complementation studies:
Test whether the recombinant P. amoebophila fmt can rescue E. coli fmt deletion mutants, which would validate its in vivo functionality

Activity can be measured under various pH, temperature, and ionic strength conditions to determine optimal reaction parameters.

  • What tRNA structural elements are recognized by P. amoebophila fmt?

While P. amoebophila fmt-specific recognition elements haven't been explicitly characterized, studies on bacterial fmt recognition of tRNA substrates provide insights:

Key recognition elements likely include:

  • A73, G2·C71, C3·G70, and G4·C69 as positive determinants in the acceptor stem

  • Absence of G·C or C·G base pairs between positions 1-72, which act as negative determinants

The acceptor arm plays a major role in formylase recognition, as demonstrated by experiments with E. coli tRNAs. It was shown that a single change of the G1·C72 base-pair to C1-A72 in elongator tRNA^Met makes it formylatable . P. amoebophila fmt likely follows similar recognition patterns given the conserved nature of the formylation reaction across bacterial species.

For experimental validation, researchers should construct chimeric tRNAs with swapped acceptor stems between formylatable and non-formylatable tRNAs to map the specific recognition elements.

Intermediate Research Questions

  • How does substrate specificity of P. amoebophila fmt compare with fmt from other bacterial species?

Comparative analysis suggestions:

  • Determine kinetic parameters (Km, kcat, kcat/Km) for both 10-CHO-THF and 10-CHO-DHF

  • Compare ratios of activity with different substrates across species

  • Evaluate pH and temperature optima for different substrates

Expected differences may correlate with the evolutionary position of P. amoebophila as an endosymbiont, potentially showing adaptations to its intracellular lifestyle within amoebae. The unique ecological niche may have influenced substrate preference compared to free-living bacteria.

A methodological approach would be to conduct parallel enzyme assays with P. amoebophila fmt and fmt from E. coli, other Chlamydiales, and mitochondrial fmt under identical conditions to quantify differences in substrate specificity and catalytic efficiency.

  • What is the impact of conserved residue mutations on P. amoebophila fmt activity?

Based on studies of human mitochondrial MTF mutants, mutations in certain conserved residues significantly affect enzyme activity. For example:

MutationEffect on ActivityImpact on Enzyme Function
S125L653-fold lower activityMajor disruption of catalytic function
S209L36-fold lower activityModerate impact; residual activity retained

To study P. amoebophila fmt conserved residues:

  • Perform sequence alignment with characterized fmt proteins

  • Identify conserved serine, histidine, and other catalytic residues

  • Generate site-directed mutants of these residues

  • Express and purify mutant proteins

  • Measure kinetic parameters (Vmax/Km) compared to wild-type enzyme

The strategic positioning of small aliphatic amino acids appears critical for normal fmt function . Researchers should systematically replace these residues in P. amoebophila fmt and determine their impact on enzyme structure and activity using both in vitro assays and complementation studies in fmt-deficient E. coli strains.

  • How is P. amoebophila fmt expression regulated in response to environmental conditions?

P. amoebophila fmt expression regulation likely responds to:

  • Growth phase-dependent regulation:

    • Measure fmt expression levels at different growth phases using qRT-PCR

    • Analyze promoter regions for regulatory elements

  • Folate pool status:

    • Investigate how fmt expression changes with folate availability

    • Correlate with levels of 10-CHO-THF and 10-CHO-DHF

  • Stress response:

    • Measure fmt expression during oxidative stress, nutrient limitation, and other stressors

    • Compare with expression patterns of other translation-related genes

  • Host-dependent regulation:

    • Compare fmt expression in the amoeba host versus axenic culture conditions

Experimental approach: Use RNA-Seq analysis to compare transcriptional profiles under various conditions, focusing on fmt and related genes involved in translation initiation. Complementary reporter gene assays with the fmt promoter can identify specific regulatory elements and transcription factors that modulate expression.

P. amoebophila fmt belongs to the core gene set of Chlamydiales, representing one of the 304 protein families present across all 37 analyzed Chlamydiales genomes . This core gene set constitutes approximately 26% of the average chlamydial genome, reflecting high structural stability despite wide phylogenetic relationships within the group.

The fmt gene's presence in the core genome suggests:

  • Essential role in protein synthesis initiation across all Chlamydiales

  • Conservation of formylation mechanism despite diverse host environments

  • Potential as a target for comparative studies of bacterial translation initiation

Genome-based phylogeny analysis places P. amoebophila fmt in the context of other Chlamydiales, with particular relationships to environmental chlamydiae with larger genomes (2,000+ protein-coding genes) such as Waddlia chondrophila and Simkania negevensis .

Research methods to explore this role include:

  • Comparative genomics analysis of fmt sequence conservation across Chlamydiales

  • Synteny analysis to identify gene neighborhood conservation

  • Evolutionary rate analysis to determine selective pressure on fmt relative to other core genes

Advanced Research Questions

  • How does P. amoebophila fmt utilize alternative formyl donors in different metabolic states?

Research has shown that bacterial fmt enzymes can utilize both 10-CHO-THF and 10-CHO-DHF as formyl donors . For P. amoebophila fmt, this flexibility may be particularly important given its endosymbiotic lifestyle.

Methodological approach to investigate this question:

Expected results: P. amoebophila fmt likely shows preferential use of 10-CHO-THF under normal conditions but shifts to 10-CHO-DHF during folate limitation or oxidative stress, representing a metabolic adaptation to maintain translation initiation under challenging conditions .

  • What are the structural determinants of P. amoebophila fmt catalytic mechanism compared to other bacterial formyltransferases?

To elucidate the structural determinants of P. amoebophila fmt:

  • Homology modeling and molecular dynamics:

    • Create a structural model based on solved fmt structures (PDB: 1FMT, 2FMT)

    • Identify catalytic pocket residues and substrate binding sites

    • Simulate substrate binding and catalytic reaction

  • Structural analysis experimental design:

    • Express and purify recombinant P. amoebophila fmt for crystallization

    • Attempt co-crystallization with tRNA substrate and formyl donor

    • Perform X-ray crystallography or cryo-EM analysis

  • Structure-function relationship studies:

    • Conduct alanine scanning mutagenesis of predicted catalytic residues

    • Measure kinetic parameters of mutants to identify critical residues

    • Perform thermostability assays to assess structural impact of mutations

Expected structural features may include:

  • A conserved formyltransferase fold with adaptations for the endosymbiotic lifestyle

  • Specific recognition elements for binding the unique P. amoebophila initiator tRNA

  • Potential structural adaptations for functioning in the intracellular environment of amoebae

  • How can researchers optimize heterologous expression systems for structural and functional studies of P. amoebophila fmt?

Advanced optimization strategies for heterologous expression:

Expression SystemAdvantagesDisadvantagesOptimization Strategies
E. coli pET systemHigh yield, simplePotential inclusion bodiesLower temperature (16-18°C), co-expression with chaperones
Insect cell baculovirusBetter folding, PTMsMore complex, expensiveOptimize MOI, harvest timing, fusion tags
Cell-free expressionRapid, toxic-protein friendlyLower yield, expensiveOptimize redox conditions, add molecular chaperones

For structural studies, consider:

  • Addition of fusion partners like MBP or SUMO to enhance solubility

  • Co-expression with P. amoebophila-specific chaperones

  • Construction of truncated variants to remove flexible regions for crystallization

  • Surface entropy reduction mutations to promote crystal formation

  • Expression with seleno-methionine for phase determination in X-ray crystallography

For functional studies, optimize:

  • Co-expression with cognate P. amoebophila tRNA^fMet

  • Addition of folate pathway enzymes to ensure adequate formyl donor availability

  • Development of high-throughput activity assays compatible with structural biology pipelines

These optimizations should be systematically tested and validated using activity assays to ensure the recombinant protein maintains native functionality .

  • What implications do P. amoebophila fmt mutations have for understanding human mitochondrial fmt-related diseases?

The study of P. amoebophila fmt can provide valuable insights into human mitochondrial fmt-related diseases like Leigh syndrome :

  • Comparative mutation analysis:

    • Map P. amoebophila fmt mutations equivalent to human pathogenic mutations (S125L, S209L)

    • Determine impact on enzyme activity using in vitro assays

    • Analyze changes in protein stability and folding

  • Evolutionary conservation:

    • Identify highly conserved residues between P. amoebophila fmt and human mitochondrial fmt

    • Assess selection pressure on these residues through evolutionary rate analysis

    • Use conservation patterns to predict pathogenicity of novel mutations

  • Structure-function relationships:

    • Use P. amoebophila fmt as a model system to understand the structural basis of disease mutations

    • Develop high-throughput screening methods for potential therapeutics

  • Mechanistic insights:

    • Compare catalytic mechanisms between bacterial and mitochondrial fmt enzymes

    • Investigate how specific mutations affect substrate binding vs. catalysis

Research findings: Mutations that severely reduce fmt activity (e.g., S125L with 653-fold reduction) correlate with more severe clinical phenotypes, while mutations with moderate impact (e.g., S209L with 36-fold reduction) may allow residual activity sufficient for partial function . The endosymbiotic origin of mitochondria makes P. amoebophila fmt particularly relevant as a model system for understanding human mitochondrial disease mechanisms.

Methodology and Technical Considerations

  • What are the best practices for measuring kinetic parameters of recombinant P. amoebophila fmt?

For accurate kinetic characterization of P. amoebophila fmt:

  • Substrate preparation:

    • Enzymatically prepare Met-tRNA^fMet using purified MetRS and tRNA^fMet

    • Synthesize or purify 10-CHO-THF and 10-CHO-DHF with >95% purity

    • Verify substrate quality by analytical methods before kinetic assays

  • Steady-state kinetic measurements:

    • Use initial rate measurements (<10% substrate conversion)

    • Vary one substrate concentration while keeping others at saturation

    • Maintain enzyme concentration at least 10-fold below substrate Km

  • Activity detection methods:

    • Northern blotting with 5′-32P end-labeled DNA oligomers complementary to tRNA^fMet

    • HPLC analysis of formylated vs. non-formylated Met-tRNA

    • LC-MS/MS detection of THF formation as reaction product

  • Data analysis:

    • Fit initial rates to Michaelis-Menten equation using non-linear regression

    • For bisubstrate reactions, use appropriate models (ping-pong vs. sequential)

    • Report kcat, Km, and kcat/Km with statistical analysis of fit quality

  • Validation controls:

    • Include E. coli fmt as positive control under identical conditions

    • Use heat-inactivated enzyme as negative control

    • Test linearity with enzyme concentration

These methods have been successfully applied to similar enzymatic systems and should provide reliable kinetic parameters for P. amoebophila fmt .

  • How does the folate metabolic pathway in P. amoebophila affect fmt function and what implications does this have for experimental design?

The folate metabolic pathway directly impacts fmt function by providing the formyl donor substrates:

  • Key relationships in one-carbon metabolism:

    • FolD (methylenetetrahydrofolate dehydrogenase) converts 5,10-CH₂-THF to 10-CHO-THF

    • Fmt utilizes 10-CHO-THF and potentially 10-CHO-DHF as formyl donors

    • DHF formed as by-product must be reduced back to THF by DHFR

  • Experimental design considerations:

    • When studying fmt in vitro, ensure adequate supply of folate cofactors

    • Consider including FolD in coupled enzyme assays to regenerate formyl donors

    • For in vivo studies, monitor folate pool status alongside fmt activity

  • Technical approach for folate-fmt pathway analysis:

    • Develop LC-MS/MS methods to quantify folate intermediates in P. amoebophila

    • Measure fmt activity in relation to folate pool composition

    • Test sensitivity to antifolates like trimethoprim that affect folate metabolism

  • Expected pathway characteristics:

    • P. amoebophila likely enriches 10-CHO-DHF during stationary phase

    • Format metabolism likely interfaces with purine biosynthesis, amino acid metabolism, and peptidoglycan synthesis

    • Folate stress would impact fmt activity and potentially protein synthesis initiation

Research implications: Understanding the interconnection between folate metabolism and fmt activity is essential for designing experiments that accurately reflect physiological conditions and interpreting results in the context of cellular metabolism .

  • What computational approaches can be used to predict substrate specificity and inhibitor binding for P. amoebophila fmt?

Advanced computational approaches for studying P. amoebophila fmt include:

  • Homology modeling and molecular dynamics:

    • Build structural models based on solved fmt structures (PDB: 1FMT, 2FMT)

    • Perform molecular dynamics simulations to study protein flexibility

    • Identify binding pocket characteristics and conformational changes

  • Substrate docking and binding energy calculations:

    • Dock 10-CHO-THF and 10-CHO-DHF into the active site

    • Calculate binding free energies using MM/PBSA or FEP methods

    • Identify key residues for substrate specificity through interaction analysis

  • Virtual screening for potential inhibitors:

    • Create pharmacophore models based on substrate binding mode

    • Screen chemical libraries for molecules matching pharmacophore

    • Rank candidates by predicted binding affinity and drug-like properties

  • Machine learning approaches:

    • Train models on known fmt inhibitors and substrates

    • Use sequence-based features and structural descriptors

    • Apply deep learning for binding affinity prediction

  • Quantum mechanical calculations:

    • Model transition state structures for catalytic mechanism elucidation

    • Calculate activation barriers for rate-limiting steps

    • Compare reaction pathways with different substrates

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.